Deep Genomics applies machine learning to develop new genetic medicines - U of T Engineering News
Genetic mutations are the cause of countless diseases and disorders, from cancer to autism to cystic fibrosis. Now, startup company Deep Genomics is applying decades of research into machine learning and genomic science to develop genetic medicines - accelerating treatments that address the root causes of these conditions.
Machine Learning, Artificial Intelligence, and Deep Learning News around the world. We publish the latest developments and advances in these fields.
Thursday, May 11, 2017
Deep Genomics applies machine learning to develop new genetic medicines
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment